Cyclacel Pharmaceuticals, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q2 2024.
  • Cyclacel Pharmaceuticals, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 864 %, a 1705% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 864 +817 +1705% Jun 30, 2024
Q1 2024 338 +307 +963% Mar 31, 2024
Q4 2023 139 +116 +496% Dec 31, 2023
Q3 2023 80.8 +63.3 +362% Sep 30, 2023
Q2 2023 47.9 +33.4 +229% Jun 30, 2023
Q1 2023 31.8 +19.9 +167% Mar 31, 2023
Q4 2022 23.4 +14 +149% Dec 31, 2022
Q3 2022 17.5 +8.99 +106% Sep 30, 2022
Q2 2022 14.5 +5.67 +64% Jun 30, 2022
Q1 2022 11.9 +2.31 +24.1% Mar 31, 2022
Q4 2021 9.4 -2.76 -22.7% Dec 31, 2021
Q3 2021 8.5 -7.33 -46.3% Sep 30, 2021
Q2 2021 8.86 -10.4 -53.9% Jun 30, 2021
Q1 2021 9.58 -15.9 -62.4% Mar 31, 2021
Q4 2020 12.2 -12.5 -50.8% Dec 31, 2020
Q3 2020 15.8 -8.94 -36.1% Sep 30, 2020
Q2 2020 19.2 -5.86 -23.4% Jun 30, 2020
Q1 2020 25.5 +0.91 +3.7% Mar 31, 2020
Q4 2019 24.7 +0.5 +2.07% Dec 31, 2019
Q3 2019 24.8 +3.02 +13.9% Sep 30, 2019
Q2 2019 25.1 +4.77 +23.5% Jun 30, 2019
Q1 2019 24.6 +1.97 +8.72% Mar 31, 2019
Q4 2018 24.2 -0.68 -2.73% Dec 31, 2018
Q3 2018 21.8 -7.97 -26.8% Sep 30, 2018
Q2 2018 20.3 -15.3 -42.9% Jun 30, 2018
Q1 2018 22.6 -14.2 -38.7% Mar 31, 2018
Q4 2017 24.9 -12.3 -33% Dec 31, 2017
Q3 2017 29.7 -5.62 -15.9% Sep 30, 2017
Q2 2017 35.6 +2.97 +9.11% Jun 30, 2017
Q1 2017 36.8 +7.46 +25.4% Mar 31, 2017
Q4 2016 37.1 +8.3 +28.8% Dec 31, 2016
Q3 2016 35.4 +5.52 +18.5% Sep 30, 2016
Q2 2016 32.6 +2.12 +6.96% Jun 30, 2016
Q1 2016 29.4 -0.77 -2.55% Mar 31, 2016
Q4 2015 28.8 -2.41 -7.72% Dec 31, 2015
Q3 2015 29.8 +0.63 +2.16% Sep 30, 2015
Q2 2015 30.5 +0.63 +2.11% Jun 30, 2015
Q1 2015 30.2 +1.93 +6.84% Mar 31, 2015
Q4 2014 31.2 +0.38 +1.23% Dec 31, 2014
Q3 2014 29.2 -10.9 -27.1% Sep 30, 2014
Q2 2014 29.8 -17.5 -36.9% Jun 30, 2014
Q1 2014 28.2 -34.9 -55.3% Mar 31, 2014
Q4 2013 30.9 -22.2 -41.9% Dec 31, 2013
Q3 2013 40.1 -1.15 -2.79% Sep 30, 2013
Q2 2013 47.3 +13.2 +38.5% Jun 30, 2013
Q1 2013 63.1 +30.6 +94% Mar 31, 2013
Q4 2012 53.1 Dec 31, 2012
Q3 2012 41.2 Sep 30, 2012
Q2 2012 34.1 Jun 30, 2012
Q1 2012 32.5 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.